In present study synthesis of 99m Tc-triamcinolone acetonide ( 99m Tc-TA) complex and its stability using set of quality control parameters such as ligand concentration, reducing agent concentration, pH, temperature and reaction time was assessed. Tc-TA complex was characterized in terms of percent (%) yield, stability in saline and serum using chromatographic procedures. Radiochemically the 99m Tc-TA complex was found quite stable in saline and serum. After 30 min of reaction the complex showed maximum radiochemical yield of 96.32% which decreased to 96.25 % after 4 h incubation period. In serum, the % yield of radiochemical was remained same up to 2 h which decreased to 93.5% at 24 h time point. Normal biodistribution pattern in Sprague-Dawley rats revealed liver, stomach and kidneys as areas of high Tc-TA complex could be further studied to identify the inflammation based diseases.
INTRODUCTION
With the invention of radiopharmaceuticals to study disease status, extensive debate was reported to manage worldwide infection threat. Within few decades thousands of repots were published to address early diagnosis strategy using radiolabeled compounds. [1] [2] [3] Although very sensitive and sophisticated diagnostic modalities such as computed tomography (CT) and magnetic resonance imaging (MRI), and number of biochemical testsare in use worldwide to assess infectious and malignant diseases, the radiopharmaceuticals were developed for early diagnosis and targeted therapy. The only bottlenecks associated with CT and MRI scan are their diagnostic ability after certain morphological and entomological changes in diseased body tissues, and absence of discrimination potential between infection and inflammation. 4 Various radiopharmaceuticals, such as radiolabeled white blood cells, 5, 6 antibiotics, 7 synthetic organic moieties, 8 antimicrobial peptides, 3 antibodies, 9 and peptide hormone analogue 10, 11 have been developed in pursuing early detection of infection and malignancies.
The radiolabeled leukocytes, 12 citrate, 13 human polyclonal immunoglobulin (HIG), 14 ubiquicidin-29-41 peptide 15 and antibiotic 1, 7 were studied to diagnose and discriminate infections from inflammations. 16 One of the clinically most popular antibiotics, ciprofloxacin was labeled with Technetium-99m (Tc99m/ 99m Tc) and provided to oncological centers with trade name infecton® for specific imaging of infections. 17 However, previous and recently reported data showed contradiction while discriminating infection from inflammation.
18
Other antimicrobial agents belonging to different classes of antibiotics specifically from flouroquinolones and cephalosporin family were also investigated to overcome non-specificity issue but the required and potential results were not achieved 16, 19 Triamcinolone acetonide (TA), a synthetic glucocorticoid i.e. fluoroquinolones used as a potential anti-inflammatory agent under certain conditions such as eczema, psoriasis, arthritis, allergies also including ulcerative colitis, sympathetic ophthalmia, and ocular inflammations. 20 It also appeared as an anticancer agent. The anti-inflammatory properties of this compound have been demonstrated to inhibit the expression of the VEGF gene. 21, 22 In present study, we describe the radiolabeling of TA with Tc-99m ( Figure  1 ), in vitro saline and serum stability, normal biodistribution in rats and scintigraphic imaging using rabbits for potential inflammationimaging agent.
EXPERIMENTAL

Materials and methods
Triamcinolone acetonide was obtained from Sigma-Aldrich, ITLC from Agilent (Germany), Deluxe electrophoresis chamber (Gelman) system (Germany), Rats (Spragur-Dawley) from NationalInstitute of Health (NIH)
Islamabad. All chemical used were on analytical grade (Sigma-Adrich). Tc generator (PINSTECH, Islamabad). The animal ethics committee of the institute gave an ethical approval for the animal experiments.
Synthesis of 99m
Tc-TA complex In six sterilized nitrogen filled vials, reducing agent (SnCl 2 .2H 2 O) 2-5 µg with an increment of 0.5 µg were taken. Then, ~ 370 MBq 99m TcO 4 -saline solution (0.8 mL) was added in each vial. Thereafter, 100 to 600 mg TA with an increment of 100 mg was added in each vial. The pH of each vial (reaction mixture) was adjusted 3 to 8 with 1 unit rise followed by incubation at room temperature and starts to monitor radiolabeling from 5 min to 6 h with definite time intervals. using. While 2 µL reaction mixture was spotted at base line on ITLC-SG strip and developed with 0.5 M NaOH solution to determine reduced and hydrolyzed fractions After complete development the both radiochromatograms were dried and scanned with 2π-Scanner (Berthold, Germany). The radiochemical complex stability was monitored periodicallyfor 24 h at room temperature. Each experiment was repeated thrice.
Quality control
In vitro stabilityin human serum
In vitro effect of blood serum on stability of the 99m Tc-TA was studied by mixingserum (1.8 mL) with 99m Tc-TA (0.2 mL) followed by incubation at 37 ºC. At pre-defined time points up to 24 h, 0.2 mL aliquots were withdrawn and spotted at ITLC to determine the percent of 
Electrophoresis of 99m
Tc-TA The qualitative net charge on 99m Tc-TA was determined with electrophoresis procedure. The process was carried out by spotting 0.2 mL Tc-TA at the center of the 30 cm long strip of Whatman No. 1 chromatographic paper. Electrophoresis was run for 60 to 90 min at a voltage of 300 V usingphosphate buffer of pH 6.8. After completion of electrophoresis, the strip was scanned by using 2π scanner to know the charge on 99m Tc-TA complex.
Biodistribution study of 99m
Tc-TA in normal rats Biodistribution in normal animal model was performed usingmale Sprague-Dawley rats weighing ~250 g. The distribution protocol was used as described previously. 2 Before administration of 99m Tc-TA, the rats were properly monitored atleast for one day.On the day of biodistribution study, 0.2 mL of 99m Tc-TA (~110 MBq) was injected into the tail vein. Three rats were used for one set of experiment. After a definite time, the rats were sacrificedby the decapitation under chloroform anesthesiaat 1, 4 and 24 h post-injection. One milliliter samples of blood were collected by cardiac puncture at the time of decapitation. Activity in total blood was calculated by assuming blood volume is 5% of the total body weight. Thereafter all organs (muscle, liver, spleen, lungs, kidney, stomach, femur, heart and brain) were dissected, weighed and their radioactivity was measured using a well-type NaI(Tl) detector connected witha single channel c-counter (SR-7). Results were expressed as percent of theinjected dose per organ. The experiment was performed in a group of three rats for one time point.
Scintigraphy of
99m Tc-TA in normal rabbit A single headed Siemens Integrated ORBITER Gamma Camera System interfaced with high-resolution parallel hole collimator was used for scintigraphic study. It was connected to an on-line dedicated computer (Macintosh ® Operating System 7.5 Software used on the ICON ™ Workstation). Previously reported protocol was adopted for scintigraphic study, 2 briefly 0.2 mL of 99m Tc-TA (~110MBq) was injected into the ear vein of each rabbit which was then placed on a flat hard surface with both hind legs spread out, and all legs fixed with surgical tape. Diazepam (5 mg) was injected to left thigh muscle for anesthetic purpose. Biodistribution of 99m Tc-TA in the body was assessed by whole body acquisition at1, 4 and 24 h of post-injection.
3.
RESULTS AND DISCUSSION
Effect of different parameters on radiochemical yield
Radiochemical yield was assessed using a set of different parameters such as reducing agent, reaction pH, ligand concentration, reaction incubation period while keeping the radionuclide activity constant i.e. 370 MBq to achieve stable and maximum radiochemical yield and purity. Tc-TA complex; the oxygen from hydroxyl and carbonyl carbon from two molecule of TA make coordination bond and present at apex of the complex while oxygen from reduced TcO core present at pyramid of the complex. Tc to oxidation states of +6 to +1; for Tc-99m, the +5 oxidation state is best suited for complexing with most antibacterial agents 23 . Stannous chloride dihydrate appeared well famed in Tc-99m complex chemistry due to its easy availability and solution formation for reduction process. It was observed in its lower oxidation state Tc-99m firmly tagged with TA and resulted a stable 99m Tc-TA complex. The maximum radiochemical yield (97.18 %) was obtained with 2.5 µg SnCl 2 .2H 2 O after 30 min of reaction mixture incubation at room temperature.
Effect of reducing agent
As shown in Figure 2 only optimal concentration (2.5 µg) of SnCl 2 .2H 2 O results maximum yield; less than optimal concentration incomplete reduction of Tc-99m lead to weak complexation and finally low radiochemical yield. While in case of higher concentration it hydrolyzed and interfere in Tc-99m complexation with TA which results in lowering the overall percentage yield of 99m Tc-TA complex. Figure 3 shows the results obtained at different pH of reaction mixture. Similar trend was observed in radiochemical yield as was observed in reducing consequently resulted in lower radiochemical yield while released (nonbounded) Tc-99m was converted into hydrolyzed form which is the main impurity of Tc-99m based radiopharmaceuticals.
Effect of pH
Effect of TA concentration
As shown in Figure 4 , the maximum radiochemical yield (96.89 %) was obtained at 300 µg substrate amount in reaction mixture. However, other than optimum ligand concentration the radiochemical yield was not greater than 96.89 %. The selection of ligand concentration while labeling with radionuclide based on experimental trails because stochiometric relation between Tc99m and ligand concentration was not known; that's way particular ligand concentration could not be chosen. Low concentration of ligand resultedin the formation of hydrolyzed technetium colloid from reduced Tc-99m. A slight decrease in complex yield was observed at higher increments of ligand concentrations might be due to the exchanged ligand phenomenon.
Effect of incubation on 99m
Tc-TA complex The stability of the complex was assessed up to 4 h. The results showed 99m Tc-TA complex remained stable up to monitored time span and no decrease in complex yield was noted as shown in Figure 5 . It apparently shows that 99m Tc-TA complex could be administered up to 4 h after reconstitution of radiolabeled compounds. Tc-TA complex stability at room temperature.
Chromatographic characterization
Radiochemical purity and yield were assessed with ITLC and paper chromatography. In paper chromatography using acetone as mobile solvent, free Tc-TA complex were calculated fromtwo chromatographic patterns ( Figure 6 ).
After studying all parameters it was observed that using 2. Tc was calculate using both chromatograms.
Stability in blood serum
As shown in Table, incubation of   99m Tc-TA complex in normal human blood serum for 24 h at physiological temperature (37 ºC) resulted in slight decrease in 99m Tc-TA complex % yield (2%). The complex appeared quite stable against action of serum on 99m Tc-TA complex; indicating safe transportation of radio-complex to target site.
Electrophoresis analysis
Electrophoresis of 99m Tc-TA complex showed it is a neutral complex moiety. The whole activity remained at place of sample introduction (center of the electrophoretic paper) while a small fraction of free 99m TcO 4 − was traveled toward anode (Figure 7) . Tc-TA complexof as it didn't travelled to any electrode.
Cell permeability shows quite sensitivity for net charge on molecule. Polar and charged molecules do not diffuse easily through the lipid core of the plasmaand consequently unable to interact with cell machinery to play diagnostic or therapeutic role. Neutral structure of 99m Tc-TA complex can approach into cell plasma through cell membrane.
Biodistribution and scintigraphy
The tissue distribution of 99m Tc-TA in different organs of normal rat model (represented as percent of injected dose per organ (%ID/organ) at 1, 4 and 24 h after intravenous administration is shown in Figure 8 . The only organs which showed high initial uptake were liver and stomach at 1 h post injection of 99m Tc-TA (12.67 ± 1.67% & 8.44 ± 1.18%, respectively) due to initial high flux of blood stream toward these organs in addition to other body tissues. However after 24 h post injection period the initial activity was reduced to 5.45 ± 1.01% & 4.11 ± 0.87%, respectively in both organs.
Figure8. The biodistribution of the 99m
Tc-TA complex in per gram of liver, spleen, stomach, intestine, kidney, lungs, femur, bladder, heart, blood, brain and carcase.
The high uptake in kidney after 1 h 99m Tc-TA administration is due to the excretory passage which reduced to a trace quantity (0.65 ± 0.11%) after 24 h. Trace amount of activity at 24 h post injection might be due to the slow release of activity from liver, stomach and blood for excretion. Intestine showed slight increase in activity at each higher time point, possibly due to slow penetration into and difficult removal from intestine. Due to the uptake of 99m Tc-TA in appreciable quantity by liver the tracer could not be suggested for liver disorder imaging; however rapid elimination from kidneys indicates the tracer is quite safe to use for different inflammatory diseases imaging. The normal scintigraphic distribution imaging study at 1 and 4 h time point well correlated with normal biodistribution study (Figure 9 ). The tracer is clearly visible at 1 and 4h post administration in liver, kidneys and bladder. However at 24 h time point activity was only seen in kidney and bladder and no activity counts was noted in liver that show the rapid clearance from non targeted organ accept kidney and bladder which are excretory pathway of metabolic products. 
CONCLUSIONS
Different radio-tracers were developed previously to discriminate infections from inflammation either tagging 99m Tc (in its lower oxidation state) with leukocytes, antibiotics or antimicrobial peptides but non-recognizable effort was done to develop inflammation imaging agent 3, 16 . TA is an antiinflammatory agent that specifically binds to inflammation associated cells to stop the inflammation process.The labeling of TA with Tc-99m could be advantageous in imaging inflammatory diseases. This study represents a comprehensive strategy to develop Tc-99m labeled TA using different reaction parameters which resulted > 96% labeling yield. Based on the results obtained the probability of Tc-TA complex for inflammation imaging could be further investigated.
